1. Home
  2. FOA vs NKTX Comparison

FOA vs NKTX Comparison

Compare FOA & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finance of America Companies Inc.

FOA

Finance of America Companies Inc.

N/A

Current Price

$11.34

Market Cap

221.6M

Sector

Finance

ML Signal

N/A

Logo Nkarta Inc.

NKTX

Nkarta Inc.

N/A

Current Price

$1.49

Market Cap

198.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FOA
NKTX
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
221.6M
198.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
FOA
NKTX
Price
$11.34
$1.49
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
★ $24.50
$10.50
AVG Volume (30 Days)
84.4K
★ 1.6M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 216.95
11.88
EPS
N/A
★ N/A
Revenue
★ $497,432,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.93
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 47.09
N/A
52 Week Low
$9.71
$1.13
52 Week High
$29.79
$3.72

Technical Indicators

Market Signals
Indicator
FOA
NKTX
Relative Strength Index (RSI) 45.14 37.50
Support Level $10.17 N/A
Resistance Level $11.81 $1.88
Average True Range (ATR) 1.07 0.18
MACD 0.29 0.01
Stochastic Oscillator 51.21 48.08

Price Performance

Historical Comparison
FOA
NKTX

About FOA Finance of America Companies Inc.

Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: